These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30960908)

  • 41. Cell Membrane-Camouflaged Nanocarriers for Cancer Diagnostic and Therapeutic.
    Li S; Liu J; Sun M; Wang J; Wang C; Sun Y
    Front Pharmacol; 2020; 11():24. PubMed ID: 32116701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Using design of experiments (DoE) to optimize performance and stability of biomimetic cell membrane-coated nanostructures for cancer therapy.
    Ferreira NN; Miranda RR; Moreno NS; Pincela Lins PM; Leite CM; Leite AET; Machado TR; Cataldi TR; Labate CA; Reis RM; Zucolotto V
    Front Bioeng Biotechnol; 2023; 11():1120179. PubMed ID: 36815878
    [No Abstract]   [Full Text] [Related]  

  • 43. Cell Membrane-Coated Nanoparticles for Precision Medicine: A Comprehensive Review of Coating Techniques for Tissue-Specific Therapeutics.
    Fernández-Borbolla A; García-Hevia L; Fanarraga ML
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment.
    Li R; He Y; Zhang S; Qin J; Wang J
    Acta Pharm Sin B; 2018 Jan; 8(1):14-22. PubMed ID: 29872619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: A review.
    He Z; Zhang Y; Feng N
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110298. PubMed ID: 31753336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stem cell membrane-camouflaged targeted delivery system in tumor.
    Zhang W; Huang X
    Mater Today Bio; 2022 Dec; 16():100377. PubMed ID: 35967738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy.
    Zhao X; Yan C
    Nanoscale Res Lett; 2022 Mar; 17(1):36. PubMed ID: 35316443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent progress in cancer cell membrane-based nanoparticles for biomedical applications.
    Lin Q; Peng Y; Wen Y; Li X; Du D; Dai W; Tian W; Meng Y
    Beilstein J Nanotechnol; 2023; 14():262-279. PubMed ID: 36895440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biologically inspired stealth - Camouflaged strategies in nanotechnology for the improved therapies in various diseases.
    Imran M; Gowd V; Saha P; Rashid S; Ahmad Chaudhary A; Mohamed MYA; Alawam AS; Khan R
    Int J Pharm; 2023 Jan; 631():122407. PubMed ID: 36402290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles.
    Li H; Jin K; Luo M; Wang X; Zhu X; Liu X; Jiang T; Zhang Q; Wang S; Pang Z
    Cells; 2019 Aug; 8(8):. PubMed ID: 31412631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homotypic Cell Membrane-Cloaked Biomimetic Nanocarrier for the Targeted Chemotherapy of Hepatocellular Carcinoma.
    Liu X; Sun Y; Xu S; Gao X; Kong F; Xu K; Tang B
    Theranostics; 2019; 9(20):5828-5838. PubMed ID: 31534522
    [No Abstract]   [Full Text] [Related]  

  • 52. Bioengineered Abiotic Nanomaterials Through Cell Membrane-Camouflaging: Advancements and Challenges in Lung Cancer.
    Jin X; Lopes D; Lopes J; Hua Z; Lei Y; Ghanbari R; Nazarzadeh Zare E; Borzacchiello A; Karimi Male H; Iravani S; Sillanpää M; Prakash C; Wang X; Cláudia Paiva-Santos A; Makvandi P; Xu Y
    Adv Healthc Mater; 2024 Nov; 13(28):e2401525. PubMed ID: 38978444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA.
    Chen M; Chen M; He J
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1635-1641. PubMed ID: 31027450
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biomimetic Targeting of Nanoparticles to Immune Cell Subsets via Cognate Antigen Interactions.
    Luk BT; Jiang Y; Copp JA; Hu CJ; Krishnan N; Gao W; Li S; Fang RH; Zhang L
    Mol Pharm; 2018 Sep; 15(9):3723-3728. PubMed ID: 29533668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biointerface engineering nanoplatforms for cancer-targeted drug delivery.
    Zhang H; Dong S; Li Z; Feng X; Xu W; Tulinao CMS; Jiang Y; Ding J
    Asian J Pharm Sci; 2020 Jul; 15(4):397-415. PubMed ID: 32952666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer Cell Membrane Camouflaged Cascade Bioreactor for Cancer Targeted Starvation and Photodynamic Therapy.
    Li SY; Cheng H; Xie BR; Qiu WX; Zeng JY; Li CX; Wan SS; Zhang L; Liu WL; Zhang XZ
    ACS Nano; 2017 Jul; 11(7):7006-7018. PubMed ID: 28665106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging.
    Rao L; Meng QF; Bu LL; Cai B; Huang Q; Sun ZJ; Zhang WF; Li A; Guo SS; Liu W; Wang TH; Zhao XZ
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2159-2168. PubMed ID: 28050902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer Cell Membrane-Camouflaged Nanorods with Endoplasmic Reticulum Targeting for Improved Antitumor Therapy.
    Zhang W; Yu M; Xi Z; Nie D; Dai Z; Wang J; Qian K; Weng H; Gan Y; Xu L
    ACS Appl Mater Interfaces; 2019 Dec; 11(50):46614-46625. PubMed ID: 31747243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythrocyte Membrane-Camouflaged IR780 and DTX Coloading Polymeric Nanoparticles for Imaging-Guided Cancer Photo-Chemo Combination Therapy.
    Yang Q; Xiao Y; Yin Y; Li G; Peng J
    Mol Pharm; 2019 Jul; 16(7):3208-3220. PubMed ID: 31145853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surface-Layer Protein-Enhanced Immunotherapy Based on Cell Membrane-Coated Nanoparticles for the Effective Inhibition of Tumor Growth and Metastasis.
    Wu M; Liu X; Bai H; Lai L; Chen Q; Huang G; Liu B; Tang G
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9850-9859. PubMed ID: 30788951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.